US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on Feb. 24 for "Pharmaceutical composition using endogenous cells for preventing or treating musculoskeletal disorders" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,405, issued on Feb. 24, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Pharmaceutical composition using endogenous cells for preventing or treating musculoskeletal disorders" was invented by Hyun Chul Jo (Seoul, South Korea) and Seung Yeon Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharmaceutical composition for preventing or treating musculoskeletal disease, which has the effect of proliferating endogenous cells in bone marrow. More specifically, the pharmaceutical composition of the present disclosure can be used for the treatment of musculoskeletal d...